Comparison of agar dilution and broth microdilution methods for Clostridium difficile antimicrobial susceptibility testing.

[1]  R. Saito,et al.  Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[2]  H. Lai,et al.  Molecular Epidemiology of Clostridium difficile at a Medical Center in Taiwan: Persistence of Genetically Clustering of A−B+ Isolates and Increase of A+B+ Isolates , 2013, PloS one.

[3]  M. Rupnik,et al.  Antimicrobial susceptibility of animal and human isolates of Clostridium difficile by broth microdilution. , 2013, Journal of medical microbiology.

[4]  A P MacGowan,et al.  EUCAST expert rules in antimicrobial susceptibility testing. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  M. Kaku,et al.  Antimicrobial susceptibilities of Clostridium difficile isolated in Japan , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  G. Kahlmeter,et al.  Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  M. Okazaki,et al.  Molecular and Microbiological Characterization of Clostridium difficile Isolates from Single, Relapse, and Reinfection Cases , 2011, Journal of Clinical Microbiology.

[8]  E. Goldstein,et al.  Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile. , 2011, Diagnostic microbiology and infectious disease.

[9]  T. Peláez,et al.  Reassessment of Clostridium difficile Susceptibility to Metronidazole and Vancomycin , 2002, Antimicrobial Agents and Chemotherapy.